News Detail
Mumbai, 16 April 2023: India, which accounted for 83 per cent of all malaria deaths in Southeast Asia last year, is seeing some hope as a malaria pill has reached phase-2 clinical trials.
While Ghana recently approved Oxford and Serum Institute......
View Details
While Ghana recently approved Oxford and Serum Institute......
View Details
Source : Business Standard
Zydus
Malaria
malaria vaccines
drug
cadila
usfda
world malaria report
zydus group
cadila healthcare
human clinical trials
vaccine
Cadila Healthcare
coronavirus
the indican council of medical research
Animal studies
potential covid-19 vaccine
pandemic
Zydus Cadila Healthcare Ltd
the union health ministry
Related News
- Gujarat FDCA attributes 45% of drug samples failing quality tests due to dissolution testing (25-09-2023)
- CDSCO says samples labelled as Cipla's and Sun Pharma's drugs failed in July could be spurious (25-09-2023)
- Govt in process of identifying additional regulatory interventions to stop Misuse of Antimicrobials (25-09-2023)
- Resistance to last-resort antibiotics Carbapenem growing in India: ICMR report (25-09-2023)
- 4 arrested with 375 bottles of Eskuf cough syrup worth Rs 4 lakh (25-09-2023)
- Ghaziabad: Fake Augmentin 625 Duo and Ultracet worth Rs 8 lakh seized, four arrested (24-09-2023)
- Police recovered 292 intoxicating capsules and 5760 pills in Ambala (24-09-2023)
- One Arrested by Cachar Police with 18,000 Yaba Tablets (24-09-2023)
- Indian-origin girl receives first rejection-free kidney from mother in UK (24-09-2023)
- 3D-printed medical devices gain ground (24-09-2023)